Skip to main content
. 2011 Jul;80(1):97–109. doi: 10.1124/mol.111.071308

TABLE 3.

Abl kinase inhibition with STI571 and broad-spectrum tyrosine kinase inhibition with herbimycin A differentially affect α3*-nAChR distribution

Analysis of confocal images from CG neurons in 4-day cultures immunolabeled with mAb35 and mAbh10 to detect α3*-nAChR clusters and their overlap with SV2-containing presynaptic terminals, respectively. nAChR clusters were identified and analyzed in regions of interest (ROIs) from surface (en-face) optical sections as described under Materials and Methods. Overall intensity applies to the mean mAb35 (α3*-nAChR) fluorescence intensity within selected en-face ROIs; Rm indicates Manders coefficient for α3*-nAChR/SV2 colocalization. Other parameters indicate α3*-nAChR cluster or synaptic puncta size, density, and intensity as indicated in the text. STI571 (top) was applied at 10 μM for 24 h; herbimycin A (bottom) was applied at 0.5 μg/ml for 24 h. Both were compared with separate sham-treated controls from the same experiments.

α3*-nAChR Labeling
α3*-nAChR/SV2 Overlap
Cluster Size Cluster Density Cluster Intensity Overall Intensity Rm Puncta Size Puncta Density Puncta Intensity
μm2 μm2 ΔF/Fb ΔF/Fb μm2 μm−2 ΔF/Fb
Control (n = 11) 0.24 ± 0.03 0.35 ± 0.02 14.5 ± 0.7 2.6 ± 0.5 0.60 ± 0.04 0.12 ± 0.01 0.17 ± 0.02 18.3 ± 0.7
STI571 (n = 10) 0.29 ± 0.03 0.29* ± 0.02 13.5 ± 0.5 2.2 ± 0.3 0.55 ± 0.05 0.15 ± 0.02 0.16 ± 0.02 17.1 ± 0.5
    p Values 0.25 < 0.05 0.26 0.79 0.45 0.20 0.73 0.18
Control (n = 7) 0.22 ± 0.02 0.34 ± 0.01 19.7 ± 1.5 3.5 ± 0.3 N.D. N.D. N.D. N.D.
Herbimycin A (n = 9) 0.14 ± 0.04 0.05 ± 0.01* 16.1 ± 1.2 0.7* ± 0.1 N.D. N.D. N.D. N.D.
    p Values 0.10 < 0.0001 0.08 < 0.0001

N.D., not done.

*

Parameter values in the STI571-treated group that are significantly different from those in sham-treated controls (P < 0.05, Student's unpaired two-tailed t test).